766 results on '"Chen, Hong-Zhuan"'
Search Results
2. GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma
3. Strategic Licensing Model Choice with Network Effects in a Dynamic Duopoly
4. Liposomes-enabled cancer chemoimmunotherapy
5. A phosphoglycerate mutase 1 allosteric inhibitor restrains TAM-mediated colon cancer progression
6. Price and cooperation decisions in a cooperative R&D supply chain with different licensing models
7. p85S6K sustains synaptic GluA1 to ameliorate cognitive deficits in Alzheimer’s disease
8. Trimmable bandgap reference circuit with exponential curvature compensation
9. Cancer cell-autonomous cGAS-STING response confers drug resistance
10. A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinoma
11. A fungal dioxygenase CcTet serves as a eukaryotic 6mA demethylase on duplex DNA
12. Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb–drug interactions in antiviral therapy
13. A nano-innate immune system activator for cancer therapy in a 4T1 tumor-bearing mouse model
14. Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancer.
15. Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity
16. Inhibition of drug-metabolizing enzymes by Qingfei Paidu decoction: Implication of herb-drug interactions in COVID-19 pharmacotherapy
17. A two-sided matching model for complex equipment production of military–civilian merging platform with reference effects
18. Oncolytic Peptide‐Nanoplatform Drives Oncoimmune Response and Reverses Adenosine‐Induced Immunosuppressive Tumor Microenvironment.
19. HKB99, an allosteric inhibitor of phosphoglycerate mutase 1, suppresses invasive pseudopodia formation and upregulates plasminogen activator inhibitor-2 in erlotinib-resistant non-small cell lung cancer cells
20. PKC and Ras are Involved in M1 Muscarinic Receptor-Mediated Modulation of AMPA Receptor GluA1 Subunit
21. Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition
22. A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer
23. M1 Muscarinic Receptor Activation Rescues β-Amyloid-Induced Cognitive Impairment through AMPA Receptor GluA1 Subunit
24. Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer’s disease-related pathologies in a senescence-accelerated mouse model
25. Helicobacter pylori FabX contains a [4Fe-4S] cluster essential for unsaturated fatty acid synthesis
26. Correction to: LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis
27. Imaging asparaginyl endopeptidase (AEP) in the live brain as a biomarker for Alzheimer’s disease
28. M1 muscarinic receptors facilitate hippocampus-dependent cognitive flexibility via modulating GluA2 subunit of AMPA receptors
29. STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma
30. Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemia
31. Discovery of the covalent SARS‐CoV‐2 Mpro inhibitors from antiviral herbs via integrating target‐based high‐throughput screening and chemoproteomic approaches
32. The Molecular Basis of Catalysis by SDR Family Members Ketoacyl‐ACP Reductase FabG and Enoyl‐ACP Reductase FabI in Type‐II Fatty Acid Biosynthesis
33. Targeted Micellar Phthalocyanine for Lymph Node Metastasis Homing and Photothermal Therapy in an Orthotopic Colorectal Tumor Model
34. WSB1/2 target chromatin-bound lysine-methylated RelA for proteasomal degradation and NF-κB termination.
35. Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy
36. Strategic Licensing Model Choice with Network Effects in a Dynamic Duopoly
37. Discovery of the covalent SARS-CoV-2 M pro inhibitors from anti-viral herbs via integrating target-based high-throughput screening and chemoproteomic approaches
38. A mucoactive drug carbocisteine ameliorates steroid resistance in rat COPD model
39. Tumor priming using metronomic chemotherapy with neovasculature-targeted, nanoparticulate paclitaxel
40. ERRATUM: Cytokine Storm in Acute Viral Respiratory Injury: Role of Qing-Fei-Pai-Du Decoction in Inhibiting the Infiltration of Neutrophils and Macrophages through TAK1/IKK/NF-κB Pathway.
41. LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis
42. miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson’s disease
43. Licensing pricing discrimination and allocative efficiency about the Chinese dual-use defense technology under a military shareholding contract.
44. Metal‐Coordinated Adsorption of Nanoparticles to Macrophages for Targeted Cancer Therapy (Adv. Funct. Mater. 19/2023)
45. Supplementary Legends and Figure S1-S8 from Acquired Resistance to EGFR TKIs Mediated by TGFβ1/Integrin β3 Signaling in EGFR-Mutant Lung Cancer
46. Supplementary methods and materials and supplementary Tables S1-S3 from Acquired Resistance to EGFR TKIs Mediated by TGFβ1/Integrin β3 Signaling in EGFR-Mutant Lung Cancer
47. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy
48. Raddeanin A, a triterpenoid saponin isolated from Anemone raddeana, suppresses the angiogenesis and growth of human colorectal tumor by inhibiting VEGFR2 signaling
49. Carbocysteine restores steroid sensitivity by targeting histone deacetylase 2 in a thiol/GSH-dependent manner
50. Additional file 1 of p85S6K sustains synaptic GluA1 to ameliorate cognitive deficits in Alzheimer’s disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.